Cours BioRestorative Therapies, Inc. Other OTC
Actions
BRTX
US0906554086
Recherche biotechnologique et médicale
CA 2024 * | 60 k 54,35 k | CA 2025 * | 60 k 54,35 k | Capitalisation | 9,27 M 8,4 M |
---|---|---|---|---|---|
Résultat net 2024 * | -17 M -15,4 M | Résultat net 2025 * | -20 M -18,12 M | VE / CA 2024 * | 155 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 155 x |
PER 2024 * |
-0,64
x | PER 2025 * |
-0,65
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 81,2% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01/10/18 |
Robert Kristal
DFI | Director of Finance/CFO | - | 04/11/21 |
Compliance Officer | 55 | 01/09/15 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 29/10/21 |
David Rosa
BRD | Director/Board Member | 59 | 29/10/21 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13/04/11 |
Varia. 1 janv. | Capi. | |
---|---|---|
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |